Sandra Luna Fineman

M.D. | Pediatric Hematology-Oncology | Female

Sandra Luna Fineman, M.D. is a San Francisco, California based Pediatric doctor with medical specialization in Pediatric Hematology-Oncology. Current practice location of Sandra Luna Fineman is 3700 California St, 1550, San Francisco, California - 94118-1618. She can be contacted on phone at 415-600-0750. Sandra Luna Fineman is a sole proprietor of her business.
NPI number (Unique professional ID) for Sandra Luna Fineman is 1447272281 which was assigned by NPPES on 24 Jul, 2006 and it was last updated on 07 Oct, 2009. Sandra Luna Fineman license number is A44996 for Pediatrics Pediatric Hematology-Oncology (2080P0207X) in California.
Sandra Luna Fineman is trained in the combination of pediatrics, hematology and oncology to recognize and manage pediatric blood disorders and cancerous diseases.
Complete Profile:
Sandra Luna Fineman basic information including her official name, gender, specialization, credentials etc. are as mentioned below.
Specialization :Pediatrics Pediatric Hematology-Oncology
Provider Name :Sandra Luna Fineman
Credential :M.D.
Gender :Female
Business Address:
Sandra Luna Fineman address, contact phone number and fax are as below. Patients can directly walkin to the clinic or can call on the below given phone number for appointment.
Primary Address :3700 California St, 1550
San Francisco, CA, 94118-1618
United States
Phone Number :415-600-0750
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number : 1447272281
NPI Entity Type : Individual
First Enrolment Date : 24 Jul, 2006
Last Updated On : 07 Oct, 2009
Medicare Participation:
Sandra Luna Fineman participates in medicare and accepts medicare insurance either directly or through association with group practice or medical facility.
Medicare PECOS ID :2062429509
Medicare Enrollment ID :I20171114000926
Primary Specialty :Hematology/oncology
Medical School :Other
Graduation Year :1984
Accepts Medicare?Yes. Sandra Luna Fineman accepts medicare insurance.
Group Practice Association:
Sandra Luna Fineman is associated with following Group Practice Organizations. Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name with which Sandra Luna Fineman is associated with along with the number of members in that group. She may also accept medicare indirectly via these group practices.
Organisation Name :Group Practice IDNo. of MembersPractice AddressGroup Accepts Medicare
University Physicians Incorporated3476465667251813123 E 16th Ave
Children's Hospital Colorado
Aurora, CO - 800457106
Ph: 7207771234
Yes
Licenses and Specialities:
Physicians/Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Sandra Luna Fineman are as mentioned. Primary taxonomy code for Sandra Luna Fineman, M.D. is 2080P0207X (Pediatrics Pediatric Hematology-Oncology).
Taxonomy Code SpecialityPrimaryLicense No.State
2080P0207XPediatrics Pediatric Hematology-OncologyYesA44996CA
Legacy Identifiers:
Other legacy medical identifiers of Sandra Luna Fineman such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned below.
IdentifierIdentifier TypeStateIssuer
00A449960MEDICAIDCA
Mailing Address:
Mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned business address only.
Mailing Address :Po Box 254947
Sacramento, CA, 95865-4947
United States
Phone Number :916-854-6975
Fax Number :916-854-6864
Business Location:
Patients can refer following map for directions to Sandra Luna Fineman practice address. Don't forget to take prior appointment before visiting.

** Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 January, 2024.